The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•11 February 2026•

1 min read

Quest Diagnostics Shares Surge on Robust 2025 Earnings and Optimistic 2026 Outlook

3D metallic 'PVH' text with 'CALVIN KLEIN' and 'TOMMY HILFIGER' names. Upward trend line, 'EARNINGS BEAT', 'REVENUE: +14%', and '2026 GUIDANCE' on an orange background.

Quest Diagnostics (NYSE: DGX) witnessed a significant surge in its share price, climbing 6.56%, following the release of its robust fourth-quarter and full-year 2025 earnings report. The diagnostic information services provider announced substantial growth in both revenue and earnings per share (EPS) for the fiscal year 2025, surpassing market expectations. Furthermore, the company provided an optimistic outlook for 2026, projecting continued expansion across its top and bottom lines. This strong performance is attributed to resilient demand for diagnostic testing services and the successful execution of strategic initiatives. Investors reacted positively to the impressive financial results and the confident future guidance, signaling strong market confidence in the company's trajectory.